Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
Conditions: Ovarian Tumor; Ovarian Cancer Interventions: Other: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasound in according with the IOTA definitions is performed. Sponsors: Maxima Medical Center; Radboud University Medical Center; The Netherlands Cancer Institute; Catharina Ziekenhuis Eindhoven; ZonMw: The Netherlands Organisation for Health Research and Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome
Conditions: PCOS; Vitamin D Interventions: Drug: Vitamin D3; Drug: Placebo Oral Tablet Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics
Conditions: Premature Ovarian Insufficiency; Metabolomics; Traditional Chinese Medicine; Mechanism; Clinical Syndrome Interventions: Drug: Jiajian Guishen Formulation Sponsors: Shi Yun Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
Conditions: Ovarian Cancer Recurrent Interventions: Drug: Fluzopril Combined With Apatinib Sponsors: Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery
Conditions: Ovarian Neoplasm Epithelial Interventions: Other: acute normovolemic hemodilution (ANH); Other: acute hypervolemic hemodilution (AHH) Sponsors: Zhejiang Cancer Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
Conditions: PCOS; Vitamin D Interventions: Drug: Vitamin D3 Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women
Conditions: Infertility, Female; Oocyte Maturation Interventions: Drug: Controlled ovarian stimuation; Procedure: Oocyte pick up; Procedure: Oocyte in vitro maturation; Procedure: Oocyte in vitro activation Sponsors: Instituto Valenciano de Infertilidad, IVI VALENCIA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy
Conditions: Polycystic Ovary Syndrome Interventions: Procedure: laparoscopy / laparotomy; Other: NO INTERVENTION Sponsors: Asian Institute of Gastroenterology, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The effects of intermittent fasting diet alone or in combination with probiotic supplementation in comparison with calorie-restricted diet on metabolic and hormonal profile in patients with polycystic ovary syndrome: study protocol for a randomized clinical trial
DiscussionWe hypothesized that 10-h TRE administered alone or in combination with probiotic supplementation to overweight and obese PCOS subjects would lead to weight loss and improved metabolic, hormonal, inflammatory, and antioxidant markers compared to control subjects following a standard 3-meal-per-day CR diet.Ethical aspectsThe current trial received approval from the Medical Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.MEDICNE.REC.1401.425).Trial registrationIranian Registry of Clinical Trials IRCT20121110011421N5. Registered on 3 October 2022. (Source: Trials)
Source: Trials - October 25, 2023 Category: Research Source Type: clinical trials
the Correlation Between Ovarian Function and Serum Biomarkers
Conditions: Premature Ovarian Insufficiency; Diminished Ovarian Reserve; Biomarker; Copper; Ceruloplasmin; Aging Interventions: Diagnostic Test: blood test Sponsors: Shi Yun Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders
Conditions: Infertility Interventions: Procedure: duostim vs. two antagonist ovarian stimulations Sponsors: Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Conditions: Cancer; Tumor, Solid; Malignant Neoplasm; Metastatic Cancer; Advanced Solid Tumor; Platinum-resistant Ovarian Cancer; Cutaneous Squamous Cell Carcinoma Interventions: Drug: OR502; Drug: Cemiplimab Sponsors: OncoResponse, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
Conditions: Infertility Interventions: Drug: GenSci094; Drug: Placebo RecFSH / follitropin alfa; Biological: Biological: RecFSH / Follitropin alfa (Days 1 to 7); Drug: Placebo GenSci094; Biological: RecFSH / Follitropin alfa (Days 8 to hCG); Drug: Ganirelix; Biological: hCG; Drug: Progesterone Sponsors: Changchun GeneScience Pharmaceutical Co., Ltd.; Sixth Affiliated Hospital, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)
Conditions: Poor Ovarian Response Interventions: Drug: Jiajian Guishen granules; Drug: coenzyme Q10 Sponsors: Shi Yun; Xiyuan Hospital, China Academy of Traditional Chinese Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Conditions: Epithelial Ovarian Cancer Interventions: Diagnostic Test: Hematologic features Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
